- Home
- LBRDK vs ICLR Comparison
LBRDK vs ICLR Comparison
Compare LBRDK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDK
- ICLR
- Stock Information
- Founded
- LBRDK 2014
- ICLR 1990
- Country
- LBRDK United States
- ICLR Ireland
- Employees
- LBRDK N/A
- ICLR N/A
- Industry
- LBRDK Cable & Other Pay Television Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LBRDK Telecommunications
- ICLR Health Care
- Exchange
- LBRDK Nasdaq
- ICLR Nasdaq
- Market Cap
- LBRDK 13.0B
- ICLR 13.7B
- IPO Year
- LBRDK N/A
- ICLR 1998
- Fundamental
- Price
- LBRDK $60.09
- ICLR $173.13
- Analyst Decision
- LBRDK
- ICLR Buy
- Analyst Count
- LBRDK 0
- ICLR 15
- Target Price
- LBRDK N/A
- ICLR $209.93
- AVG Volume (30 Days)
- LBRDK 1.0M
- ICLR 1.1M
- Earning Date
- LBRDK 11-06-2025
- ICLR 10-22-2025
- Dividend Yield
- LBRDK N/A
- ICLR N/A
- EPS Growth
- LBRDK 36.76
- ICLR 13.11
- EPS
- LBRDK 7.58
- ICLR 9.73
- Revenue
- LBRDK $1,052,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- LBRDK $6.59
- ICLR N/A
- Revenue Next Year
- LBRDK $2.22
- ICLR $1.73
- P/E Ratio
- LBRDK $7.89
- ICLR $17.51
- Revenue Growth
- LBRDK 7.24
- ICLR N/A
- 52 Week Low
- LBRDK $56.04
- ICLR $125.10
- 52 Week High
- LBRDK $97.38
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- LBRDK 37.09
- ICLR 51.75
- Support Level
- LBRDK $58.90
- ICLR N/A
- Resistance Level
- LBRDK $61.36
- ICLR $176.07
- Average True Range (ATR)
- LBRDK 1.64
- ICLR 6.17
- MACD
- LBRDK 0.58
- ICLR -7.19
- Stochastic Oscillator
- LBRDK 55.06
- ICLR 94.78
About LBRDK Liberty Broadband Corporation Class C
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.